Kim Lennart Dueholm
Keine laufenden Positionen mehr
Ursprung des Netzwerks ersten Grades von Kim Lennart Dueholm
| Einheit | Art der Einheit | Industrie | |
|---|---|---|---|
University of Copenhagen
72
| College/University | Other Consumer Services | 72 |
| Public Company | Pharmaceuticals: Major | 16 | |
Novo Ventures 1 A/S
 Novo Ventures 1 A/S Investment ManagersFinance Novo Ventures (Novo Ventures) is a venture capital operating division of Novo Nordisk Fonden. It engages in investment activities. The firm was established in 1999, and is headquartered in Hellerup, Denmark.
14
| Operating Division | Investment Managers | 14 |
University of Southern Denmark
4
| College/University | Other Consumer Services | 4 |
Unternehmensgrafik - zweiten Grades
Beziehungen zu mehreren Unternehmen
Unternehmensverbindungen über das persönliche Netzwerk von Kim Lennart Dueholm
| Unternehmen | Sektor | Verknüpfte Personen | Hauptposition |
|---|---|---|---|
Novo Holdings AS (Denmark)
 Novo Holdings AS (Denmark) Financial ConglomeratesFinance Novo Holding A/S provides financial investments and manages the Novo Nordisk Foundation?s assets. It offers seed and venture capital to development stage companies and takes ownership positions in companies within life science and biotechnology. The company was founded on September 8, 1999 and is headquartered in Hellerup, Denmark. | Financial Conglomerates | Chairman Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal Director of Finance/CFO Chief Investment Officer Chief Executive Officer | |
| NOVO NORDISK A/S | Pharmaceuticals: Major | Director/Board Member Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal Director/Board Member Director/Board Member Director/Board Member Corporate Officer/Principal | |
| Technical University of Denmark | College/University | Graduate Degree Graduate Degree Graduate Degree Undergraduate Degree Corporate Officer/Principal Graduate Degree Masters Business Admin Doctorate Degree | |
Aerpio Therapeutics, Inc.
 Aerpio Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Aerpio Therapeutics, Inc. operates as a clinical-stage biopharmaceutical company focused on advancing innovative therapies for vascular diseases. The firm develops small molecules and monoclonal antibodies for the treatment of vascular disease and enhancement of wound healing. Its two lead programs include a tie-2 activator for diabetic macular edema and vascular leak, and a hypoxia-inducible factor 1-a stabilizer for wound healing and the treatment of inflammatory bowel disease. The company was founded by Joseph H. Gardner and Robert Shalwitz in 2011 and is headquartered in Cincinnati, OH. | Pharmaceuticals: Major | Chairman Director/Board Member Founder Director/Board Member Corporate Officer/Principal | |
| Copenhagen Business School | College/University | Undergraduate Degree Graduate Degree Masters Business Admin Masters Business Admin Masters Business Admin | |
Genzyme Corp.
 Genzyme Corp. Medical SpecialtiesHealth Technology Genzyme Corp. engages in development and manufacture of specialty therapeutic, surgical and diagnostic product. It serves in the areas of rare genetic diseases, multiple sclerosis, cardiovascular diseases and endocrinology. The company was founded on June 8, 1981 and is headquartered in Cambridge, MA. | Medical Specialties | Director of Finance/CFO Corporate Officer/Principal Comptroller/Controller/Auditor General Counsel | |
Copenhagen Infrastructure Partners P/S
 Copenhagen Infrastructure Partners P/S Investment ManagersFinance Copenhagen Infrastructure Partners P/S (CIP) is a private equity firm founded- in 2012 by Jakob Baruël Poulsen, Christian Skakkebæk, Torsten Lodberg Smed, and Rune Bro Róin. The firm is headquartered in Copenhagen, Denmark. | Investment Managers | Private Equity Investor Founder Chief Executive Officer Private Equity Investor | |
| H. LUNDBECK A/S | Pharmaceuticals: Major | Chief Executive Officer Director/Board Member Sales & Marketing Public Communications Contact | |
Novo Nordisk Fonden
 Novo Nordisk Fonden Investment Trusts/Mutual FundsMiscellaneous Novo Nordisk Fonden provides basis for the commercial and research activities conducted by the companies. It also supports scientific and humanitarian purposes activities. It awards grants for research within biomedicine, biotechnology, general practice and family medicine, nursing, and art history at public research institutions. It bridges gap between the discoveries made by researchers in biomedicine and biotechnology and their commercial application. The company was founded by August Krogh, Marie Krogh, Harald Pedersen, Hans Christian Hagedorn, August Kongsted and Thorvald Pedersen in 1922 and is headquartered in Hellerup, Denmark. | Investment Trusts/Mutual Funds | Chairman Chief Executive Officer Chief Executive Officer | |
Kanyos Bio, Inc.
 Kanyos Bio, Inc. Pharmaceuticals: MajorHealth Technology Kanyos Bio, Inc. engages in the provision of immune tolerance technology solutions. It develops antigen-specific for treatment of type-1 diabetes and celiac disease. The company was founded by Jeffrey Hubbell, Stephan Kontos, Oscar Buset, Kristen M. Lorentz, and David A. Lowin in 2015 and is headquartered in Cambridge, MA. | Pharmaceuticals: Major | Director/Board Member Director/Board Member Director/Board Member | |
Novo Ventures (US), Inc.
 Novo Ventures (US), Inc. Investment ManagersFinance Novo Ventures (US), Inc. is a venture capital firm located in San Francisco. The firm is a subsidiary of Novo A/S and their ultimate parent is Novo Nordisk Fonden. | Investment Managers | Corporate Officer/Principal Private Equity Investor Private Equity Investor | |
| Suffolk University | College/University | Undergraduate Degree Masters Business Admin Masters Business Admin | |
Thesan Pharmaceuticals, Inc.
 Thesan Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Thesan Pharmaceuticals, Inc. provides novel therapeutics for disorders of the skin. The company focuses on the discovery and development of new chemical entities that provide improved treatment options to patients. Thesan Pharmaceuticals was founded in 2011 by Edward P. Monaghan and is headquartered in Carlsbad, CA. | Pharmaceuticals: Major | Director/Board Member Director/Board Member Director/Board Member | |
Novo Nordisk, Inc.
 Novo Nordisk, Inc. BiotechnologyHealth Technology Novo Nordisk, Inc. operates diabetes care company. It offers biopharmaceuticals, chronic weight management, human growth hormone therapy and hemophilla management services. The firm also provides rare bleeding disorders, growth hormone related disorders, and women's health. The company was founded in 1982 and is headquartered in Plainsboro, NJ. | Biotechnology | Chief Tech/Sci/R&D Officer President Director/Board Member | |
| University of Oxford | College/University | Doctorate Degree Masters Business Admin Undergraduate Degree | |
BNS Holding AB
 BNS Holding AB Financial ConglomeratesFinance Part of Melker Schörling AB (Investment Company), BNS Holding AB provides investment services. The company is based in Stockholm, Sweden. | Financial Conglomerates | Director/Board Member Director/Board Member | |
Terranol A/S
 Terranol A/S Miscellaneous Commercial ServicesCommercial Services Terranol A/S develops yeasts to be applied in second generation bioethanol production. Its second generation bioethanol is produced from agricultural wastes, such as wheat straw, sugar cane bagasse, corn stover, and wood chips. It has developed industrial yeasts that converts all sugars and also the sugar xylose in biomass into ethanol. The company's technology Terranol Strain V-1 ferments glucose and xylose into ethanol with high yield and low production of the byproduct xylitol. Terranol was founded by Thomas Hvid Andersen, Birgitte Rønnow, and Ole Sibbesen in October 2007 and is headquartered in Kongens Lyngby, Denmark. | Miscellaneous Commercial Services | Chief Executive Officer Founder | |
| Massachusetts College of Liberal Arts | College/University | Undergraduate Degree Undergraduate Degree | |
| UNITED PLANTATIONS | Agricultural Commodities/Milling | Chief Executive Officer Director of Finance/CFO | |
| UIE PLC | Agricultural Commodities/Milling | Chairman Director/Board Member | |
| KERYX BIOPHARMACEUTICALS | Pharmaceuticals: Major | Chairman President | |
Minervax ApS
 Minervax ApS Medical SpecialtiesHealth Technology Minervax ApS provides vaccine against streptococci. It utilizes fusion protein, which has proved to elicit good protective immunity. Its vaccine provides protective immunity against many clinically relevant GBS strains. The firm is engages in biotechnology, scientific and technical activities, and research and development. The company was founded in 2010 and is headquartered in Copenhagen, Denmark. | Medical Specialties | Chief Executive Officer Director/Board Member | |
| Unitata Bhd. | Chief Executive Officer Director/Board Member | ||
| Malaysian Palm Oil Association | Director/Board Member Director/Board Member | ||
Danfoss A/S
 Danfoss A/S Industrial MachineryProducer Manufacturing Danfoss A/S operates as an engineering company. The firm manufactures refrigeration, air conditioning, and industrial controls for several industries. Its products include thermostatic expansion valves, solenoid, pressure and temperature regulators, electronic controls, line components, electronically operated, coils, solenoid, pressure controls and thermostats, filter driers, sight glasses, contactors and motor starters, liquid level controls, condensing units, appliance, controls accessories and spare parts, compressors for air conditioning, heating and refrigeration, heat exchangers, and valve station. It operates through the following segments: Danfoss Power Solutions, Danfoss Climate Solutions, Danfoss Power Electronics and Drives, and Other Areas. The Danfoss Power Solutions segment establishes electric powertrain systems. The Danfoss Climate Solutions segment includes heating and cooling solutions for buildings, cold chains, industry, and infrastructure. The Danfoss Power Electronic and Drives segment focuses on the decarbonization with electric and energy solutions for vehicles and industry. The company was founded by Peter Johan Mads Clausen on September 1, 1933 and is headquartered in Nordborg, Denmark. | Industrial Machinery | Director/Board Member General Counsel | |
Falck A/S
 Falck A/S Services to the Health IndustryHealth Services Falck A/S offers emergency assistance, rescue, healthcare, and training services. It provides emergency medical services to people through their ambulances, fire-fighting, fire training, and consultancy services to industrial customers; assistance in airports within the areas of fire services and personal assistance to travelers; and fire services and emergency services in airports. The firm also facilitates roadside assistance in case of an accident or breakdown of cars, trucks, busses, caravans, trailers, bicycles, motorcycles, and boats; travel assistance services to leisure travelers, business travelers, and expatriates; and fleet management services, as well as installs and services alarms in private homes and places of businesses. It also owns shares or other securities of domestic and foreign companies. The company was founded on August 23, 2004 and is headquartered in Copenhagen, Denmark. | Services to the Health Industry | Chief Executive Officer Chairman | |
| United International Enterprises (Malaysia) Bhd. | Chairman Director/Board Member | ||
Copenhagen Infrastructure Partners P/S
 Copenhagen Infrastructure Partners P/S Investment ManagersFinance Copenhagen Infrastructure Partners P/S manages and advices investment companies. It was founded by Simon Krogh on September 6, 2016 and is headquartered in Copenhagen, Denmark. | Investment Managers | Director/Board Member Chairman | |
| DANSKE BANK A/S | Major Banks | Chief Executive Officer President | |
Realkredit Danmark A/S
 Realkredit Danmark A/S Finance/Rental/LeasingFinance Realkredit Danmark A/S engages in the financing of residential and commercial real estate. The firm also provides mortgage products through the issuance of bonds. It operates through the Mortgage Finance and Proprietary Portfolio segments. The company was founded in 1851 and is headquartered in Copenhagen, Denmark. | Finance/Rental/Leasing | Chairman Corporate Officer/Principal | |
| Government of Denmark | Sovereign | Head of Government Head of Government | |
Velux A/S
 Velux A/S Forest ProductsNon-Energy Minerals Velux A/S manufactures building materials. Its products include roof windows, modular skylights, sun tunnels, decorative elements, blinds, roller shutters, installation solutions, ventilations, and remote controls. The company was founded by Villum Kann Rasmussen in 1941 and is headquartered in Horsholm, Denmark. | Forest Products | Director of Finance/CFO Director/Board Member | |
| Danske Bank A/S (Broker) | Investment Banks/Brokers | Chief Executive Officer Chief Executive Officer | |
Falck Danmark A/S
 Falck Danmark A/S Other TransportationTransportation Falck Danmark A/S offers ambulance service, fire fighting, roadside assistance, and non-emergency patient transport. The company was founded on October 3, 1906 and is headquartered in Copenhagen, Denmark. | Other Transportation | Chief Executive Officer Director/Board Member | |
Danske Bank A/S (Investment Management)
 Danske Bank A/S (Investment Management) Investment ManagersFinance Danske Bank A/S (Investment Management) (Danske Bank-IM) is the investment management division of Danske Bank A/S (CO: DANSKE, ADR: DNKEY) in Denmark. The firm was founded in 1871 and is headquartered in Kongens Lyngby. Danske Bank-IM manages Nordic, European and Eastern European assets for institutional clients in the life and pensions sector, foundations, municipalities, corporate clients, mutual funds and retail investors. They outsource investment areas outside of their core expertise to external managers. | Investment Managers | Chief Executive Officer Corporate Officer/Principal | |
| AAK AB | Food: Specialty/Candy | Director/Board Member Director/Board Member | |
Entasis Therapeutics, Inc.
 Entasis Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Entasis Therapeutics, Inc. is a clinical-stage biopharmaceutical company, which focuses on the discovey, development, and commercialization of novel antibacterial prodcuts to treat serious infections caused by multi-drug resistant Gram-negative bacteria. Its pipeline includes ETX2514SUL, targeting Acinetobacter baumannii infections; ETX0282CPDP, targeting Enterobacteriaceae infections; a Non-Beta-lactam PBP inhibitor, targeting Gram-negative infections; and zoliflodacin, targeting Neisseria gonorrhoeae. The company was founded by Manoussos Perros in May 2015 and is headquartered in Waltham, MA. | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
F2G Ltd.
 F2G Ltd. Pharmaceuticals: MajorHealth Technology F2G Ltd. provides novel drugs for the treatment of life-threatening systemic fungal diseases. It primarily focuses on developing an F3 series of anti mould compound, which is an antifungal agent that acts through a mechanism different from marketed drugs. The company was founded in 1998 and is headquartered in Manchester, the United Kingdom. | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
Novo Holdings A/S (Investment Company)
 Novo Holdings A/S (Investment Company) Financial ConglomeratesFinance Novo Holdings A/S (Investment Company) (Novo Holdings-IC) is the investment portfolio division of Novo Holdings A/S, a holding company headquartered in Hellerup, Denmark. They are ultimately owned by Novo Nordisk Fonden (Novo Nordisk Foundation). Founded in 1999, Novo Holdings-IC manages a broad portfolio of the Foundation’s financial assets. | Financial Conglomerates | Corporate Officer/Principal Corporate Officer/Principal | |
| BIOPORTO A/S | Medical Specialties | President Director/Board Member | |
Stargazer Pharmaceuticals, Inc.
 Stargazer Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Stargazer Pharmaceuticals, Inc. manufactures pharmaceutical products. The firm engages in the development of treatment for Stargardt’s disease, a rare form of juvenile, retinal degeneration. The company was founded by Gary Jay Sternberg and is headquartered in Boston, MA. | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
Anokion SA
 Anokion SA Medical/Nursing ServicesHealth Services Anokion SA provides technology for retraining white blood cells to induce therapeutic immune tolerance. The firm?s approach to antigen-specific immune tolerance can be translated to virtually any protein in numerous clinical indications. The company was founded by Jerffery Hubbell, Melody Swartz, Stephan Kontos, Oscar Buset, Kristen M. Lorentz and David A. Lowin and is headquartered in Ecublens, Switzerland. | Medical/Nursing Services | Director/Board Member Chairman | |
Epsilon-3 Bio Ltd
 Epsilon-3 Bio Ltd Pharmaceuticals: OtherHealth Technology Epsilon-3 Bio Ltd. develops compounds targeting the removal of cellular debris in chronic inflammatory and autoimmune disorders. The company was founded by Martin W. Edwards, Konstantinos Efthymiopoulos, David J. Grainger and Christian De La Tour on June 18, 2010 and is headquartered in Cambridge, the United Kingdom. | Pharmaceuticals: Other | Founder Director/Board Member |
Statistik
International
| Dänemark | 26 |
| Vereinigte Staaten | 15 |
| Malaysia | 5 |
| Vereinigtes Königreich | 4 |
| Schweden | 3 |
Sektoral
| Health Technology | 22 |
| Finance | 11 |
| Consumer Services | 6 |
| Process Industries | 3 |
| Health Services | 3 |
Operativ
| Director/Board Member | 505 |
| Corporate Officer/Principal | 186 |
| Chairman | 136 |
| Chief Executive Officer | 102 |
| Independent Dir/Board Member | 79 |
Am stärksten vernetzte Beziehungen
| Insiders | |
|---|---|
| Eivind Kolding | 50 |
| Arne Gerlyng-Hansen | 46 |
| Martin Edwards | 38 |
| Jack Nielsen | 38 |
| Muneer Satter | 35 |
| Michael Wyzga | 31 |
| Nanna Liebach Lüneborg | 29 |
| Peter Bisgaard | 28 |
| John M. Rice | 27 |
| Lars Dybkjær | 26 |
| Peter Moldt | 25 |
| Thomas Dyrberg | 24 |
| Rasmus Lund | 24 |
| Maxine Gowen | 23 |
| Jan Ulf Sigvar J. Johansson | 23 |
- Börse
- Insiders
- Kim Lennart Dueholm
- Unternehmensverbindungen